NMFC Heads Into Q3 Print With Shorts Retreating and Insiders Buying

NMFC reports Q3 results on October 30 against a backdrop where the people closest to the company have been buying while professional short sellers have been quietly reducing pressure.

The lending market tells a notably relaxed story heading into the print. Availability has loosened sharply, rising to 99% this week from below 45% for most of October, a reversal that coincides with short interest falling 6% over the past week to roughly 3.1 million shares. Borrowing costs have also eased, dipping to 4.4% from above 5.7% at the start of the month. The ORTEX short score, though still elevated at 58.6, has declined from 62 ten days ago, a further sign that bearish conviction is fading rather than building. The stock itself is off 5% over the past month to $6.61, with BDC peers broadly softer on the day, including ARCC and FSK both down around 0.8% and TCPC sliding 2.2%.

Options positioning reinforces the bullish lean. The put/call ratio has collapsed to near its 52-week low of 0.015, more than 1.2 standard deviations below its 20-day average of 0.05. That extreme call dominance is unusual for a name heading into earnings and suggests options traders are positioned for upside rather than protection.

The analyst community has spent the better part of 2026 trimming targets without changing their neutral-to-negative stance. Wells Fargo cut its target to $7.50 in August, and Keefe, Bruyette & Woods moved to $8.00 in July, both maintaining hold-equivalent ratings. BofA Securities downgraded NMFC to Underperform back in September 2025, a move that has aged into the current price at $6.61. The consensus sits well above the current share price, but the direction of travel has been consistently downward. The valuation picture is consistent with a troubled BDC: price-to-book is 0.61, and the P/E of 6.2 has compressed roughly 5% over the past 30 days.

The most notable ownership story centres on Steven Klinsky, the company's founder and largest shareholder, who accumulated over 800,000 shares across multiple open-market purchases at prices of $8.05 to $8.17 in March. Those purchases were made as a Schedule 13D filer with activist-level disclosure, lifting his stake to 12.5% of the class. His last reported holding of 12.3 million shares was filed in March, and as of that point he remains the dominant insider presence. A director also sold 77,500 shares at $7.89 in June, though that sale is now several months dated. Stakes disclosed under 13D/G rules are "as last disclosed" around the 5% threshold, and positions can change without a further filing.

Thursday's print is effectively a test of whether NMFC's floating-rate portfolio has continued to generate net investment income sufficient to cover the dividend and whether credit quality across its middle-market loans has held up as the rate cycle matures.